Skip to main content

Table 2 Odds Ratios for Colorectal Cancers and Colorectal Adenomas including high- and low-risk adenomas for MDR1 G-rs3789243-A

From: The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study

 

NCase

NControl

ORa

95% CI

ORb

95% CI

Colorectal Cancer

      

   GG

50

101

1.00

-

1.00

-

   GA

78

190

0.80

(0.53–1.22)

0.79

(0.44–1.41)

   AA

39

104

0.73

(0.45–1.20)

0.55

(0.27–1.12)

   GA and AA

117

294

0.78

(052–1.15)

0.70

(0.41–1.21)

Colorectal Adenomas

      

   GG

253

101

1.00

-

1.00

-

   GA

482

190

1.01

(0.76–1.35)

0.98

(0.73–1.35)

   AA

234

104

0.90

(0.65–1.24)

0.93

(0.65–1.33)

   GA and AA

716

294

0.97

(0.74–1.27)

0.96

(0.72–1.29)

High-risk adenomas

      

   GG

61

101

1.00

-

1.00

-

   GA

109

190

0.95

(0.64–1.41)

1.08

(0.69–1.70)

   AA

54

104

0.86

(0.54–1.36)

0.98

(0.58–1.64)

   GA and AA

163

294

0.92

(0.63–1.33)

1.04

(0.68–1.59)

Low-risk adenomas

      

   GG

192

101

1.00

-

1.00

-

   GA

373

190

1.03

(0.77–1.39)

0.98

(0.71–1.36)

   AA

180

104

0.91

(0.65–1.28)

0.93

(0.64–1.36)

   GA and AA

553

294

0.99

(0.75–1.31)

0.97

(0.71–1.32)

  1. aCrude.
  2. bAdjusted for age and gender.